Pantoprazole and Abreva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pantoprazole (pantoprazole sodium) and Abreva (docosanol). Common drug interactions include anxiety among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Pantoprazole and Abreva. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,167 Pantoprazole users. Check the latest studies of Pantoprazole.

What is Abreva?

Abreva has active ingredients of docosanol. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 17,071 Abreva users. Check the latest studies of Abreva.

On Jul, 31, 2026

22 people who take Pantoprazole and Abreva together, and have interactions are studied.

Pantoprazole and Abreva drug interactions.

What are the common drug interactions of Pantoprazole and Abreva, by gender? *:

female:

Anxiety
Chest pain
Daydreaming
Flushing (the warm, red condition of human skin)
Heart rate increased
Injection site erythema (redness at injection site)
Injection site mass
Injection site pain
Injection site pruritus (severe itching at injection site)
Injection site reaction

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Dyspnoea (difficult or laboured respiration)
Eye discharge
Local swelling (swelling at the site of some application of substance or injury)
Muscular weakness (muscle weakness)
Oral herpes (viral infection of mouth)
Pulmonary embolism (blockage of the main artery of the lung)
Rhinorrhoea (watery mucus discharge from the nose)
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Pantoprazole and Abreva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anxiety
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Chest pain
Daydreaming
Depression
Emotional distress
Flushing (the warm, red condition of human skin)
Heart rate increased
Injection site erythema (redness at injection site)
Injection site mass

40-49:

n/a

50-59:

Chills (felling of cold)
Fatigue (feeling of tiredness)
Infusion site erythema (reddening of the skin at infusion site)
Urinary tract infection
Headache (pain in head)
Infusion site bruising
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Infusion site pain
Injection site swelling
Pharyngitis (inflammation of the pharynx, causing a sore throat)

60+:

Drug ineffective
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Oxygen saturation decreased
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pulmonary embolism (blockage of the main artery of the lung)
Rhinorrhoea (watery mucus discharge from the nose)
Asthma
Dacryostenosis acquired (obstruction of the nasolacrimal duct-acquired)
Dyspnoea (difficult or laboured respiration)
Eye discharge

What are the existing conditions these people have? *

Bone Disorder: 6 people, 27.27%
Bone Density Abnormal: 5 people, 22.73%
Hiv Infection: 3 people, 13.64%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 9.09%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 9.09%
Multiple Myeloma (cancer of the plasma cells): 2 people, 9.09%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and Abreva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously